TGFB1 and COVID-19: We hypothesized that in certain survivors of ARDS secondary to COVID-19, the overexpression of TGF-β1, both in plasma and airways, may mediate fibroblast activation, prompting early alterations in the cellular repair process that may potentially result in long-term fibrosis.